Fundamentals

Valuation

Metric	Q3	Q1	Δ in %
EV/EBITDA	1249.53	-2115.74	156.78
Graham Fair Price	-26.70	2.71	3.70
PEG	-62.76	0.20	-0.55
Price/Book	-23.77	3.65	4.79
Price/Cash Flow	-10.04	-74.39	82.70
Prices/Earnings	34.15	-117.06	87.26
Price/Sales	-15.31	25.51	30.12
Price/FCF	-10.04	-74.39	82.70
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q1	Δ in %
Gross Profit Margin	-8.68	0.60	0.65
Operating Margin	-49.22	-0.05	0.10
ROA	-42.54	< 0.005	0.01
ROE	0.01	< 0.005	-43.17
ROIC	< 0.005	< 0.005	-3076.05
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q1	Δ in %
Debt QOQ	-0.06	-1.00	93.65
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.71	0.44	-74.05
EPS QOQ	1.60	-5.76	260.26
FCF QOQ	7.98	-1.72	-78.49
Revenue QOQ	0.45	0.13	-70.24
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	76.94	81.96	6.53
Inventory Turnover	0.00	46151000.00	100.00
Debt/Capitalization	1.02	< 0.005	-99.83
Quick Ratio	3.87	3.96	2.33
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q1	Δ in %
Book Value	6.66	6.47	-2.76
Cash	5.48	5.03	-8.25
Capex	-0.01	< 0.005	85.00
Free Cash Flow	0.39	-0.32	-17.59
Revenue	1.06	0.93	-12.47
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q1	Δ in %
Current Ratio	3.97	4.05	2.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-32.52	569.78	1652.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating